Document is current
Any future updates will be listed below
-
Authors
Wilding, John https://orcid.org/0000-0003-2839-8404
- License Information
-
More Information
Article History
First Online: 15 October 2020
Competing interests
: J.W. has received funding (paid to his employer) for attending advisory boards from Astellas, AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Merck, Mundipharma, Napp, Novo Nordisk, Rhythm Pharmaceuticals, Sanofi, Takeda and Wilmington Healthcare; has received travel grants to attend conferences and/or lecture fees from AstraZeneca, Boehringer Ingelheim, Mundipharma, Napp, Novo Nordisk and Sanofi; and has received institutional research grant support or funding for clinical trials from AstraZeneca, Novo Nordisk and Takeda.
